Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of “Hold” from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have earned a consensus recommendation of “Hold” from the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $66.50.

A number of equities research analysts have commented on AGL shares. Wells Fargo & Company restated an “overweight” rating and set a $141.00 target price (up from $72.00) on shares of Agilon Health in a research note on Monday, July 13th. Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $33.00 to $49.00 in a research note on Thursday, May 7th. Citigroup downgraded shares of Agilon Health from a “neutral” rating to a “sell” rating and raised their price objective for the company from $80.00 to $105.00 in a research report on Thursday, July 23rd. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. Finally, Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price for the company in a report on Tuesday, May 26th.

Hedge Funds Weigh In On Agilon Health

A number of hedge funds have recently made changes to their positions in the business. CIBC Bancorp USA Inc. bought a new stake in Agilon Health during the 3rd quarter valued at approximately $34,000. Tower Research Capital LLC TRC boosted its stake in Agilon Health by 214.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company’s stock worth $85,000 after purchasing an additional 25,270 shares during the period. Prudential Financial Inc. grew its holdings in Agilon Health by 70.7% during the 2nd quarter. Prudential Financial Inc. now owns 40,880 shares of the company’s stock valued at $94,000 after buying an additional 16,928 shares in the last quarter. LPL Financial LLC grew its holdings in Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after buying an additional 30,000 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new stake in shares of Agilon Health during the second quarter valued at approximately $106,000.

Agilon Health Stock Performance

NYSE:AGL opened at $92.97 on Thursday. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a 50-day simple moving average of $105.67 and a two-hundred day simple moving average of $52.72. The firm has a market capitalization of $1.55 billion, a PE ratio of -4.31 and a beta of 2.98. Agilon Health has a 52-week low of $7.48 and a 52-week high of $133.04.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.76. The firm had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. Analysts forecast that Agilon Health will post -3.5 EPS for the current year.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.